CTRI/2021/03/032211尚未招募3 期
Role of Mifepristone in cervical ripening for induction of labour in non high risk pregnant women - A Double Blind Randomized Controlled Trial
SHAILY TYAGI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients giving consent for study
- •Singleton pregnancy
- •Gestational age >= 40 completed weeks (Gestation age confirmed by earliest ultrasound and reliable date of last menstrual period) with cephalic presentation
- •Adequate pelvis
- •Bishop score <6
- •Reactive NST
- •Age >18 â?? 35 year.
排除标准
- •Patients not giving consent for the study
- •Multiple pregnancy
- •Any obstetrics contraindication for induction of labour (previous scar on uterus, any coagulation failure, placenta previa)
- •Patients with any other associated medical condition like gestational diabetes mellitus, hypertension, sepsis, pyrexia, disease which contraindicates the use of mifepristone like adrenal insufficiency
- •Estimated fetal weight >= 4kg
- •Oligohydromnios
- •Fetal growth restriction.
研究者
相似试验
尚未招募
4 期
Study of oral Mifepristone as a cervical ripening agent to induce labour in low-risk full-term live pregnancy beyond 40 weeks of gestation.CTRI/2024/02/062460maid Hospital, Dr SN Medical College
尚未招募
3 期
se of Oral Mifepristone on an out-patient basis to aid onset of normal labour pain in low risk pregnant women more than 40 weeks of gestatioCTRI/2020/07/026333Internal Fluid Research
尚未招募
Unknown
Effect of oral misoprostol for cervical ripening in term pre-mature rupture of membrane.CTRI/2023/04/051795Maulana Azad Medical College and Lok Nayak hospital
已完成
不适用
Clinical Evaluation of Cervical Ripening in the Outpatient SettingLabor Onset and Length AbnormalitiesForced or Induced, Affecting Fetus or Newborn LaborNCT04271722Centro Hospitalar Lisboa Norte101
终止
2 期
Cervical Preparation With Mifepristone Prior to Osmotic DilatorsSecond Trimester AbortionNCT03714880University of California, Davis44